Michael Kovacs

Michael Kovacs is a declared insider of Big Pharma Split Corp., with filings sourced from SEDI. We count 4 filings; the first trade dates from 25 September 2017 and the latest from 7 October 2019.

Both buying and selling appear: 2 purchases worth €14k, against 1 sale worth €12k. On balance, insiders were net buyers of €1,651. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2019, the count stands at no purchases and 1 sale.

Most recently, on 8 October 2019, the filings show an open-market sale worth €12k in Big Pharma Split Corp. The clock since the last published purchase (21 August 2018) now reads 2,988 days. Typically, a trade is published a median of 4 days after it takes place. Until a filing is published, the market cannot know about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.